Sound Income Strategies’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-599
| Closed | -$54 | – | 1419 |
|
|
2023
Q3 | $54 | Hold |
599
| – | – | ﹤0.01% | 1124 |
|
|
2023
Q2 | $55 | Hold |
599
| – | – | ﹤0.01% | 1087 |
|
|
2023
Q1 | $156 | Hold |
599
| – | – | ﹤0.01% | 1036 |
|
|
2022
Q4 | $126 | Hold |
599
| – | – | ﹤0.01% | 965 |
|
|
2022
Q3 | $0 | Hold |
599
| – | – | ﹤0.01% | 1013 |
|
|
2022
Q2 | $0 | Hold |
599
| – | – | ﹤0.01% | 980 |
|
|
2022
Q1 | $0 | Hold |
599
| – | – | ﹤0.01% | 972 |
|
|
2021
Q4 | $1K | Hold |
599
| – | – | ﹤0.01% | 833 |
|
|
2021
Q3 | $1K | Hold |
599
| – | – | ﹤0.01% | 814 |
|
|
2021
Q2 | $1K | Hold |
599
| – | – | ﹤0.01% | 865 |
|
|
2021
Q1 | $1.21K | Hold |
599
| – | – | ﹤0.01% | 805 |
|
|
2020
Q4 | $1K | Hold |
599
| – | – | ﹤0.01% | 856 |
|
|
2020
Q3 | $2K | Hold |
599
| – | – | ﹤0.01% | 701 |
|
|
2020
Q2 | $2K | Hold |
599
| – | – | ﹤0.01% | 669 |
|
|
2020
Q1 | $0 | Hold |
599
| – | – | ﹤0.01% | 923 |
|
|
2019
Q4 | $1K | Hold |
599
| – | – | ﹤0.01% | 688 |
|
|
2019
Q3 | $0 | Hold |
599
| – | – | ﹤0.01% | 803 |
|
|
2019
Q2 | $0 | Hold |
599
| – | – | ﹤0.01% | 807 |
|
|
2019
Q1 | $2K | Hold |
599
| – | – | ﹤0.01% | 580 |
|
|
2018
Q4 | $1K | Hold |
599
| – | – | ﹤0.01% | 660 |
|
|
2018
Q3 | $3K | Hold |
599
| – | – | ﹤0.01% | 528 |
|
|
2018
Q2 | $3K | Buy |
+599
| New | +$3K | ﹤0.01% | 488 |
|